{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:45:51Z","timestamp":1790646351817,"version":"4.1.0"},"reference-count":327,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["8091\/10"],"award-info":[{"award-number":["8091\/10"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Painful peripheral neuropathy affects millions of people worldwide. Peripheral neuropathy develops in patients with various diseases, including rare familial or acquired amyloid polyneuropathies, as well as some common diseases, including type 2 diabetes mellitus and several chronic inflammatory diseases. Intriguingly, these diseases share a histopathological feature\u2014deposits of amyloid-forming proteins in tissues. Amyloid-forming proteins may cause tissue dysregulation and damage, including damage to nerves, and may be a common cause of neuropathy in these, and potentially other, diseases. Here, we will discuss how amyloid proteins contribute to peripheral neuropathy by reviewing the current understanding of pathogenic mechanisms in known inherited and acquired (usually rare) amyloid neuropathies. In addition, we will discuss the potential role of amyloid proteins in peripheral neuropathy in some common diseases, which are not (yet) considered as amyloid neuropathies. We conclude that there are many similarities in the molecular and cell biological defects caused by aggregation of the various amyloid proteins in these different diseases and propose a common pathogenic pathway for \u201cperipheral amyloid neuropathies\u201d.<\/jats:p>","DOI":"10.3390\/cells9061553","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T09:36:04Z","timestamp":1593509764000},"page":"1553","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Amyloid Proteins and Peripheral Neuropathy"],"prefix":"10.3390","volume":"9","author":[{"given":"Mohammed","family":"Albariqi","sequence":"first","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, The Netherlands"},{"name":"The National Centre for Genomic Technology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology, P.O. Box 6086, 11461 Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoukje","family":"Engelsman","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-7063","authenticated-orcid":false,"given":"Niels","family":"Eijkelkamp","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"H\u00f6ppener","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, The Netherlands"},{"name":"Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, 3584 EA Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sinico, R., and Guillevin, L. (2020). Peripheral Nervous System Involvement. Rare Diseases of the Immune System. Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis, Springer.","DOI":"10.1007\/978-3-030-02239-6"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Javed, S., Hayat, T., Menon, L., Alam, U., and Malik, R.A. (2019). Diabetic peripheral neuropathy in people with type 2 diabetes: Too little too late. Diabetic Med.","DOI":"10.1111\/dme.14194"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.mcna.2018.10.006","article-title":"Peripheral Neuropathy","volume":"103","author":"Barrell","year":"2019","journal-title":"Med. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/B978-0-12-802395-2.00031-6","article-title":"Diseases of the peripheral nerves","volume":"145","author":"Katona","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: Chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajh.24433","article-title":"Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment","volume":"91","author":"Gertz","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4161\/pri.2.3.7488","article-title":"Amyloid fibrils: Abnormal protein assembly","volume":"2","author":"Rambaran","year":"2008","journal-title":"Prion"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/13506120009146820","article-title":"The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000","volume":"7","author":"Kisilevsky","year":"2000","journal-title":"Amyloid"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","article-title":"Protein folding and aggregation into amyloid: The interference by natural phenolic compounds","volume":"14","author":"Stefani","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer\u2019s and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00415-017-8708-4","article-title":"Transthyretin familial amyloid polyneuropathy: An update","volume":"265","year":"2018","journal-title":"J. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1085-9489.2004.09405.x","article-title":"Amyloid neuropathy: A retrospective study of 35 peripheral nerve biopsies","volume":"9","author":"Vital","year":"2004","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mod.2012.11.001","article-title":"Roles of the amyloid precursor protein family in the peripheral nervous system","volume":"130","author":"Caldwell","year":"2013","journal-title":"Mech. Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/CND.0000000000000050","article-title":"Rare case of a localized radial nerve amyloid neuropathy","volume":"16","author":"Kanta","year":"2014","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1469-8749.2009.03336.x","article-title":"Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes","volume":"51","author":"Hashkes","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_23","first-page":"369","article-title":"Systemic AA amyloidosis: Epidemiology, diagnosis, and management","volume":"6","author":"Costa","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"Hoppener","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuroscience.2011.11.032","article-title":"Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer\u2019s disease","volume":"202","author":"Jolivalt","year":"2012","journal-title":"Neuroscience"},{"key":"ref_27","first-page":"363","article-title":"Peripheral neuropathy in Parkinson\u2019s disease","volume":"36","author":"Grambalova","year":"2015","journal-title":"Neuroendocrinol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/msj.21352","article-title":"Amyloid neuropathies","volume":"79","author":"Shin","year":"2012","journal-title":"Mt. Sinai J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Robles","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/bi301313b","article-title":"Age-related oxidative modifications of transthyretin modulate its amyloidogenicity","volume":"52","author":"Zhao","year":"2013","journal-title":"Biochemistry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1111\/j.1742-4658.2011.08186.x","article-title":"Understanding the complex mechanisms of beta2-microglobulin amyloid assembly","volume":"278","author":"Eichner","year":"2011","journal-title":"FEBS J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.22-14-05900.2002","article-title":"Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis","volume":"22","author":"Guo","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16115","DOI":"10.1073\/pnas.1306621110","article-title":"Pathogenetic mechanisms of amyloid A amyloidosis","volume":"110","author":"Simons","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2017.03.002","article-title":"Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?","volume":"31","author":"Zhang","year":"2017","journal-title":"Blood Rev."},{"key":"ref_35","first-page":"E1008","article-title":"Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats","volume":"271","author":"Mulder","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2798269","DOI":"10.1155\/2016\/2798269","article-title":"Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_39","first-page":"150","article-title":"Familial Amyloid Polyneuropathy","volume":"56","author":"Cakar","year":"2019","journal-title":"Arch. Neuropsychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Said","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/13506129.2018.1503593","article-title":"Hereditary transthyretin amyloidosis: Baseline characteristics of patients in the NEURO-TTR trial","volume":"25","author":"Ackermann","year":"2018","journal-title":"Amyloid"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the global prevalence of transthyretin familial amyloid polyneuropathy","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0039-1688994","article-title":"Neuropathy Associated with Systemic Amyloidosis","volume":"39","author":"Kaku","year":"2019","journal-title":"Semin. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2353\/jmoldx.2009.080161","article-title":"Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: Identification of three novel mutations in the APOA1 gene","volume":"11","author":"Eriksson","year":"2009","journal-title":"J. Mol. Diagn."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/13506129809007291","article-title":"Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide","volume":"5","author":"Kiuru","year":"1998","journal-title":"Amyloid"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/014556139807700207","article-title":"Combined bilateral submandibular and sublingual swelling, macroglossus, and carpal tunnel syndrome caused by light chain amyloidosis","volume":"77","author":"Jonsson","year":"1998","journal-title":"Ear Nose Throat J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ajh.25149","article-title":"Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment","volume":"93","author":"Gertz","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: A real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3171\/2015.10.JNS151095","article-title":"A case of isolated amyloid light-chain amyloidosis of the radial nerve","volume":"125","author":"Cheng","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1046\/j.1523-1755.2001.59780164.x","article-title":"beta2-microglobulin-derived amyloidosis: An update","volume":"78","author":"Floege","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/IJNRD.S84784","article-title":"Dialysis-related amyloidosis: Challenges and solutions","volume":"9","author":"Scarpioni","year":"2016","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e000098","DOI":"10.1161\/JAHA.113.000098","article-title":"Senile systemic amyloidosis: Clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"ref_54","first-page":"3425617","article-title":"Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function","volume":"2016","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_55","unstructured":"(2020, June 26). IDF Diabetes atlas 9th edition 2019. Available online: https:\/\/www.diabetesatlas.org\/en\/."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sun, J., Wang, Y., Zhang, X., Zhu, S., and He, H. (2020). Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis. Prim. Care Diabetes.","DOI":"10.1016\/j.pcd.2019.12.005"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Juster-Switlyk, K., and Smith, A.G. (2016). Updates in diabetic peripheral neuropathy. F1000Res, 5.","DOI":"10.12688\/f1000research.7898.1"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jfmpc.jfmpc_260_18","article-title":"Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis","volume":"8","author":"Kaeley","year":"2019","journal-title":"J. Fam. Med. Prim Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990\u20132017: A systematic analysis of the Global Burden of Disease study 2017","volume":"78","author":"Safiri","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0b013e3182904d16","article-title":"Peripheral neuropathy incidence in inflammatory bowel disease: A population-based study","volume":"80","author":"Figueroa","year":"2013","journal-title":"Neurology"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kim, S., Kang, S.J., Oh, K.W., Ahn, B.K., Lee, H.L., Han, D.S., Jang, K., and Kim, Y.S. (2015). Chronic inflammatory demyelinating polyneuropathy-like neuropathy as an initial presentation of Crohn\u2019s disease. BMC Neurol., 15.","DOI":"10.1186\/s12883-015-0302-8"},{"key":"ref_62","unstructured":"GBD 2017 Inflammatory Bowel Disease Collaborators (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol., 5, 17\u201330."},{"key":"ref_63","first-page":"10","article-title":"Updated Incidence and Prevalence of Crohn\u2019s Disease and Ulcerative Colitis in Olmsted County, Minnesota (1970\u20132011)","volume":"15","author":"Loftus","year":"2014","journal-title":"ACG 2014 Ann. Sci. Meet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ejim.2015.07.013","article-title":"Peripheral neuropathy: An underreported neurologic manifestation of inflammatory bowel disease","volume":"26","author":"Moris","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.22431","article-title":"Pain phenotype in patients with knee osteoarthritis: Classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study","volume":"67","author":"Moreton","year":"2015","journal-title":"Arthritis Care Res. Hoboken"},{"key":"ref_66","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789\u20131858."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00045391-200205000-00004","article-title":"Analgesia and the patient with osteoarthritis","volume":"9","author":"Bijlsma","year":"2002","journal-title":"Am. J. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/CND.0b013e31814839d6","article-title":"Psoriatic arthritis-associated polyneuropathy: A report of three cases","volume":"9","author":"Narayanaswami","year":"2007","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","article-title":"Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis","volume":"48","author":"Scotti","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial mediterranean Fever in the world","volume":"61","author":"Touitou","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.lpm.2018.08.014","article-title":"Familial Mediterranean Fever","volume":"48","author":"Ozdogan","year":"2019","journal-title":"Presse Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/OARRR.S114447","article-title":"Muckle-Wells syndrome: Clinical perspectives","volume":"9","author":"Tran","year":"2017","journal-title":"Open Access Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00294378","article-title":"Amyloid neuropathy: Immunocytochemical localization of intra- and extracellular immunoglobulin light chains","volume":"79","author":"Sommer","year":"1989","journal-title":"Acta Neuropathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00294814","article-title":"Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: A quantitative light and electron microscopic study of the peripheral nervous system","volume":"90","author":"Toyooka","year":"1995","journal-title":"Acta Neuropathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","article-title":"Familial amyloid polyneuropathy: Receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways","volume":"21","author":"Sousa","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jnen\/61.6.565","article-title":"Neuromuscular pathology in hereditary gelsolin amyloidosis","volume":"61","author":"Somer","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1529-8027.2012.00406.x","article-title":"Amyloid-like IgM deposition neuropathy: A distinct clinico-pathologic and proteomic profiled disorder","volume":"17","author":"Figueroa","year":"2012","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pathol.2016.08.018","article-title":"Localised SAA amyloidosis with intra-axonal intra-myelin amyloid deposits","volume":"49","author":"Gaspar","year":"2017","journal-title":"Pathology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/164_2017_3","article-title":"Mitochondria in Alzheimer\u2019s Disease and Diabetes-Associated Neurodegeneration: License to Heal!","volume":"240","author":"Cardoso","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3233\/JAD-170931","article-title":"Sweet Mitochondria: A Shortcut to Alzheimer\u2019s Disease","volume":"62","author":"Moreira","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10158-018-0221-7","article-title":"Na(+)\/K(+)-pump and neurotransmitter membrane receptors","volume":"19","author":"Pivovarov","year":"2018","journal-title":"Invert. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.rdc.2013.02.012","article-title":"Amyloidosis: A clinical overview","volume":"39","author":"Hazenberg","year":"2013","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.24725","article-title":"Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: An answer to the paradox?","volume":"80","author":"Loavenbruck","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.34.8.1025","article-title":"Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: A clinicopathologic study","volume":"34","author":"Said","year":"1984","journal-title":"Neurology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0002-9343(98)00037-0","article-title":"Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy","volume":"104","author":"Rajkumar","year":"1998","journal-title":"Am. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/13506129.2011.574354036","article-title":"Varied patterns of inaugural light-chain (AL) amyloid polyneuropathy: A monocentric study of 24 patients","volume":"18","author":"Adams","year":"2011","journal-title":"Amyloid"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nbd.2017.02.009","article-title":"Defective axonal transport: A common pathological mechanism in inherited and acquired peripheral neuropathies","volume":"105","author":"Prior","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2015.04.001","article-title":"Mitochondrial dynamics and inherited peripheral nerve diseases","volume":"596","author":"Pareyson","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CND.0b013e3181d05994","article-title":"The neuromuscular manifestations of amyloidosis","volume":"11","author":"Simmons","year":"2010","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pneurobio.2003.11.002","article-title":"Neurodegeneration in familial amyloid polyneuropathy: From pathology to molecular signaling","volume":"71","author":"Sousa","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-981-32-9636-7_24","article-title":"Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis","volume":"1190","author":"Murakami","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.2174\/138161208786404155","article-title":"Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses","volume":"14","author":"Sekijima","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4065\/83.11.1226","article-title":"Patterns of neuropathy and autonomic failure in patients with amyloidosis","volume":"83","author":"Wang","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/brain\/94.2.199","article-title":"Familial amyloid polyneuropathy: An electron microscope study of the peripheral nerve in five cases. I. Interstitial changes","volume":"94","author":"Coimbra","year":"1971","journal-title":"Brain"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/lt.21176","article-title":"Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein AI Gly26Arg: Outcome of hepatorenal transplantation","volume":"13","author":"Testro","year":"2007","journal-title":"Liver Transpl."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1212\/WNL.0000000000003362","article-title":"Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy","volume":"87","author":"Koike","year":"2016","journal-title":"Neurology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ajpath.2011.06.024","article-title":"Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I","volume":"179","author":"Rowczenio","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-5793(97)00237-8","article-title":"Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis","volume":"406","author":"Paunio","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(00)80527-9","article-title":"The crystal structure of plasma gelsolin: Implications for actin severing, capping, and nucleation","volume":"90","author":"Burtnick","year":"1997","journal-title":"Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/138920308786733912","article-title":"Plasma gelsolin: Function, prognostic value, and potential therapeutic use","volume":"9","author":"Bucki","year":"2008","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1096\/fasebj.13.12.1621","article-title":"Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin","volume":"13","author":"Westberg","year":"1999","journal-title":"FASEB J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","article-title":"Immunohistochemistry in the classification of systemic forms of amyloidosis: A systematic investigation of 117 patients","volume":"119","author":"Schonland","year":"2012","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3324\/haematol.2013.094482","article-title":"Light chain amyloidosis: The heart of the problem","volume":"98","author":"Merlini","year":"2013","journal-title":"Haematologica"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"24283","DOI":"10.18632\/oncotarget.25055","article-title":"Clinical characteristics and diagnosis of a rare case of systemic AL amyloidosis: A descriptive study","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13506120903151775","article-title":"beta(2)-microglobulin: From physiology to amyloidosis","volume":"16","author":"Heegaard","year":"2009","journal-title":"Amyloid"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-8467(94)90022-1","article-title":"Amyloid and peripheral nervous system disease","volume":"96","author":"Haan","year":"1994","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/0886022X.2012.655682","article-title":"Neuropathy in the hemodialysis population: A review of neurophysiology referrals in a tertiary center","volume":"34","author":"Walsh","year":"2012","journal-title":"Ren. Fail."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.carpath.2019.05.002","article-title":"The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis","volume":"42","author":"Morris","year":"2019","journal-title":"Cardiovasc. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ageing\/afw073","article-title":"Acute cardiac failure secondary to senile systemic amyloidosis","volume":"45","author":"Bodard","year":"2016","journal-title":"Age Ageing"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jmb.2015.10.029","article-title":"Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?","volume":"428","author":"Das","year":"2016","journal-title":"J. Mol. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","article-title":"Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity","volume":"99","author":"Hammarstrom","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/13506129.2011.574354033","article-title":"Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: Distinctive clinical features and role of light chain type in 225 patients","volume":"18","author":"Russo","year":"2011","journal-title":"Amyloid"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2169\/internalmedicine.53.0898","article-title":"Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: A retrospective study of 202 cases with a special attention to uncommon symptoms","volume":"53","author":"Matsuda","year":"2014","journal-title":"Intern. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.13156","article-title":"Guidelines on the diagnosis and investigation of AL amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fendo.2017.00343","article-title":"T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front. Endocrinol. Lausanne"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"266","DOI":"10.11613\/BM.2013.033","article-title":"Diabetes and beta cell function: From mechanisms to evaluation and clinical implications","volume":"23","author":"Cernea","year":"2013","journal-title":"Biochem. Med. Zagreb"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/dc14-0396","article-title":"beta-cell failure in type 2 diabetes: Postulated mechanisms and prospects for prevention and treatment","volume":"37","author":"Halban","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4239\/wjd.v6.i1.109","article-title":"beta-cell dysfunction: Its critical role in prevention and management of type 2 diabetes","volume":"6","author":"Saisho","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/19382014.2019.1599707","article-title":"Islet amyloidosis in a child with type 1 diabetes","volume":"11","author":"Beery","year":"2019","journal-title":"Islets"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Yoo, M., Sharma, N., Pasnoor, M., and Kluding, P.M. (2013). Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy. J. Diabetes Metab.","DOI":"10.4172\/2155-6156.S10-005"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e3255","DOI":"10.1002\/dmrr.3255","article-title":"Diabetic neuropathy: A focus on small fibres","volume":"36","author":"Malik","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11892-019-1150-5","article-title":"Painful and Painless Diabetic Neuropathies: What Is the Difference?","volume":"19","author":"Shillo","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: Advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12013-013-9609-5","article-title":"Diabetic peripheral neuropathy: Role of reactive oxygen and nitrogen species","volume":"67","author":"Premkumar","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.52.5.1256","article-title":"High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells","volume":"52","author":"Shanmugam","year":"2003","journal-title":"Diabetes"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11154-008-9104-2","article-title":"Mechanisms of disease: The oxidative stress theory of diabetic neuropathy","volume":"9","author":"Sadidi","year":"2008","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/WCO.0b013e32830b84cb","article-title":"Diabetic polyneuropathy: An update","volume":"21","author":"Zochodne","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Nucera, S., Macri, R., Scicchitano, M., Bosco, F., Scarano, F., and Ruga, S. (2019). The Role of Endothelial Dysfunction in Peripheral Blood Nerve Barrier: Molecular Mechanisms and Pathophysiological Implications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123022"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/dc14-2585","article-title":"Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort","volume":"38","author":"Lee","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MED.0000000000000320","article-title":"Mediators of diabetic neuropathy: Is hyperglycemia the only culprit?","volume":"24","author":"Grisold","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcb.240550006","article-title":"Molecular physiology of the islet amyloid polypeptide (IAPP)\/amylin gene in man, rat, and transgenic mice","volume":"55","author":"Hoppener","year":"1994","journal-title":"J. Cell Biochem."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Kiriyama, Y., and Nochi, H. (2018). Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet beta-Cells from Amylin Cytotoxicity. Cells, 7.","DOI":"10.3390\/cells7080095"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"E383","DOI":"10.1152\/ajpendo.00757.2009","article-title":"Unfolding the mechanisms of disease progression in permanent neonatal diabetes","volume":"298","author":"Dhanvantari","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s001250051175","article-title":"Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a mouse model","volume":"42","author":"Hoppener","year":"1999","journal-title":"Diabetologia"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/cbdd.12172","article-title":"Pinpointing proline substitution to be responsible for the loss of amyloidogenesis in IAPP","volume":"82","author":"Chakraborty","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ilar.47.3.225","article-title":"Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes","volume":"47","author":"Matveyenko","year":"2006","journal-title":"ILAR J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","article-title":"Amylin deposition in the kidney of patients with diabetic nephropathy","volume":"72","author":"Gong","year":"2007","journal-title":"Kidney Int."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: A second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2337\/db16-0044","article-title":"Hyperamylinemia Increases IL-1beta Synthesis in the Heart via Peroxidative Sarcolemmal Injury","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1523\/JNEUROSCI.15-11-07625.1995","article-title":"Islet amyloid polypeptide (amylin) is expressed in sensory neurons","volume":"15","author":"Mulder","year":"1995","journal-title":"J. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-328X(97)00178-2","article-title":"Islet amyloid polypeptide and calcitonin gene-related peptide expression are upregulated in lumbar dorsal root ganglia after unilateral adjuvant-induced inflammation in the rat paw","volume":"50","author":"Mulder","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0169-328X(97)00060-0","article-title":"Islet amyloid polypeptide and calcitonin gene-related peptide expression are down-regulated in dorsal root ganglia upon sciatic nerve transection","volume":"47","author":"Mulder","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)","volume":"250","author":"Mulder","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02821715","article-title":"Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: Functional implications from plasticity in expression on nerve injury and inflammation","volume":"19","author":"Mulder","year":"1999","journal-title":"Mol. Neurobiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ejp.1347","article-title":"Amylin, a peptide expressed by nociceptors, modulates chronic neuropathic pain","volume":"23","author":"Almeida","year":"2019","journal-title":"Eur. J. Pain"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0169-328X(98)00269-1","article-title":"Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice","volume":"63","author":"Mulder","year":"1998","journal-title":"Mol. Brain Res."},{"key":"ref_156","unstructured":"Asiri, M.M.H., Versteeg, S., H\u00f6ppener, J.W.M., and Eijkelkamp, N. (2019, January 4\u20137). Human IAPP mediates painful diabetic peripheral neuropathy. Proceedings of the The 11th Congress of the European Pain Federation EFIC, Valencia, Spain."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/BF00400803","article-title":"Chronic overproduction of islet amyloid polypeptide\/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia","volume":"36","author":"Hoppener","year":"1993","journal-title":"Diabetologia"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ejp.898","article-title":"Amylin modulates the formalin-induced tonic pain behaviours in rats","volume":"20","author":"Potes","year":"2016","journal-title":"Eur. J. Pain"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-160047","article-title":"Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1beta Synthesis in Brains of Alzheimer\u2019s Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats","volume":"53","author":"Verma","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020712-163913","article-title":"AA amyloidosis: Pathogenesis and targeted therapy","volume":"10","author":"Westermark","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Secondary, AA, Amyloidosis","volume":"44","author":"Papa","year":"2018","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-007-0804-x","article-title":"A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis","volume":"27","author":"Agarwal","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/art.39178","article-title":"Transthyretin deposition in articular cartilage: A novel mechanism in the pathogenesis of osteoarthritis","volume":"67","author":"Akasaki","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/13506129.2015.1115758","article-title":"Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid","volume":"23","author":"Yanagisawa","year":"2016","journal-title":"Amyloid"},{"key":"ref_166","first-page":"1039","article-title":"Amyloidosis complicating psoriatic arthritis","volume":"130","author":"Bergis","year":"2003","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1755-6686.2009.00106.x","article-title":"Crohn\u2019s disease and secondary amyloidosis: Early complication? A case report and review of the literature","volume":"35","author":"Basturk","year":"2009","journal-title":"J. Ren. Care"},{"key":"ref_168","first-page":"333","article-title":"Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn\u2019s disease: Case report and review of the literature","volume":"22","author":"Pukitis","year":"2013","journal-title":"J. Gastrointestin Liver Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2169\/internalmedicine.52.0340","article-title":"Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn\u2019s disease","volume":"52","author":"Tada","year":"2013","journal-title":"Intern. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/13506129.2019.1576606","article-title":"Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis","volume":"26","author":"Hultman","year":"2019","journal-title":"Amyloid"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.chemphyslip.2016.11.004","article-title":"Effect of lipid environment on amyloid fibril formation of human serum amyloid A","volume":"202","author":"Tanaka","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1039\/C8CC01424H","article-title":"Serum amyloid A sequesters diverse phospholipids and their hydrolytic products, hampering fibril formation and proteolysis in a lipid-dependent manner","volume":"54","author":"Jayaraman","year":"2018","journal-title":"Chem. Commun. Camb."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-319-17344-3_3","article-title":"Lipids in Amyloid-beta Processing, Aggregation, and Toxicity","volume":"855","author":"Morgado","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbamem.2014.04.011","article-title":"Fibrillation of beta amyloid peptides in the presence of phospholipid bilayers and the consequent membrane disruption","volume":"1848","author":"Qiang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0708354105","article-title":"Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane","volume":"105","author":"Engel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acschemneuro.7b00160","article-title":"Membrane Interactions of hIAPP Monomer and Oligomer with Lipid Membranes by Molecular Dynamics Simulations","volume":"8","author":"Zhang","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-3-319-17344-3_7","article-title":"The Role of Lipid in Misfolding and Amyloid Fibril Formation by Apolipoprotein C-II","volume":"855","author":"Ryan","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1038\/srep04267","article-title":"Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies","volume":"4","author":"Bram","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1039\/C6CC01248E","article-title":"Foldamer scaffolds suggest distinct structures are associated with alternative gains-of-function in a preamyloid toxin","volume":"52","author":"Kumar","year":"2016","journal-title":"Chem. Commun. Camb."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"E6507","DOI":"10.1073\/pnas.1707120114","article-title":"Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis","volume":"114","author":"Jayaraman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Sciacca, M.F.M., Tempra, C., Scollo, F., Milardi, D., and La Rosa, C. (2018). Amyloid growth and membrane damage: Current themes and emerging perspectives from theory and experiments on Abeta and hIAPP. Biochim. Biophys. Acta Biomembr.","DOI":"10.1016\/j.bbamem.2018.02.022"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Rawat, A., Langen, R., and Varkey, J. (2018). Membranes as modulators of amyloid protein misfolding and target of toxicity. Biochim. Biophys. Acta Biomembr.","DOI":"10.1016\/j.bbamem.2018.04.011"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fncel.2019.00309","article-title":"Alzheimer\u2019s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts","volume":"13","author":"Fabiani","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/978-1-4419-6327-7_13","article-title":"Amyloid peptide pores and the beta sheet conformation","volume":"677","author":"Kagan","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_185","first-page":"5","article-title":"Amyloid-beta Alzheimer targets\u2014Protein processing, lipid rafts, and amyloid-beta pores","volume":"89","author":"Arbor","year":"2016","journal-title":"Yale J. Biol. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","article-title":"Evidence for proteotoxicity in beta cells in type 2 diabetes: Toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway","volume":"176","author":"Gurlo","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_188","first-page":"1549","article-title":"Localization and Processing of the Amyloid-beta Protein Precursor in Mitochondria-Associated Membranes","volume":"55","author":"Suski","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.07.067","article-title":"EPR evidence of hydroxyl radical generation as an initiator of lipid peroxidation in amyloid beta-protein-stimulated PC12 cells","volume":"1025","author":"Hayashi","year":"2004","journal-title":"Brain Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/09298673113209990181","article-title":"4-Hydroxynonenal in the pathogenesis and progression of human diseases","volume":"21","author":"Shoeb","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1074\/jbc.M115.655183","article-title":"Amyloid-beta Peptide Abeta3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons","volume":"291","author":"Gunn","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.12830","article-title":"Reactive oxygen species and lipid peroxidation inhibitors reduce mechanical sensitivity in a chronic neuropathic pain model of spinal cord injury in rats","volume":"131","author":"Hassler","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcell.2019.00084","article-title":"Endoplasmic Reticulum Stress Coping Mechanisms and Lifespan Regulation in Health and Diseases","volume":"7","author":"Chadwick","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.brainres.2016.03.044","article-title":"Protein aggregation and ER stress","volume":"1648","author":"Lederkremer","year":"2016","journal-title":"Brain Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/iub.1386","article-title":"Endoplasmic reticulum quality control and systemic amyloid disease: Impacting protein stability from the inside out","volume":"67","author":"Chen","year":"2015","journal-title":"IUBMB Life"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"21998","DOI":"10.1074\/jbc.M602302200","article-title":"Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy","volume":"281","author":"Teixeira","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2337\/db07-0178","article-title":"Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis","volume":"56","author":"Casas","year":"2007","journal-title":"Diabetes"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db07-0197","article-title":"High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/db08-1464","article-title":"Successful versus failed adaptation to high-fat diet-induced insulin resistance: The role of IAPP-induced beta-cell endoplasmic reticulum stress","volume":"58","author":"Matveyenko","year":"2009","journal-title":"Diabetes"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Cadavez, L., Montane, J., Alcarraz-Vizan, G., Visa, M., Vidal-Fabrega, L., Servitja, J.M., and Novials, A. (2014). Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101797"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/adt.2014.591","article-title":"Assay development and multivariate scoring for high-content discovery of chemoprotectants of endoplasmic-reticulum-stress-mediated amylin-induced cytotoxicity in pancreatic beta cells","volume":"12","author":"Law","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cbin.10750","article-title":"Tat-biliverdin reductase A protects INS-1 cells from human islet amyloid polypeptide-induced cytotoxicity by alleviating oxidative stress and ER stress","volume":"41","author":"Lee","year":"2017","journal-title":"Cell Biol. Int."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ijbiomac.2017.08.089","article-title":"Protective effects of a G. lucidum proteoglycan on INS-1 cells against IAPP-induced apoptosis via attenuating endoplasmic reticulum stress and modulating CHOP\/JNK pathways","volume":"106","author":"He","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2353\/ajpath.2009.080480","article-title":"The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells","volume":"174","author":"Nishitsuji","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., and Saido, T.C. (2018). Critical review: Involvement of endoplasmic reticulum stress in the aetiology of Alzheimer\u2019s disease. Open Biol., 8.","DOI":"10.1098\/rsob.180024"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.neuropharm.2017.11.016","article-title":"Crosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer\u2019s disease","volume":"136","author":"Santos","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.expneurol.2012.11.001","article-title":"Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy","volume":"247","author":"Lupachyk","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/ars.2013.5807","article-title":"ER stress in diabetic peripheral neuropathy: A new therapeutic target","volume":"21","author":"Hinder","year":"2014","journal-title":"Antioxid. Redox. Signal."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.1510137112","article-title":"Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain","volume":"112","author":"Inceoglu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2337\/db12-0716","article-title":"Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy","volume":"62","author":"Lupachyk","year":"2013","journal-title":"Diabetes"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.brainres.2016.04.053","article-title":"Injury to the nervous system: A look into the ER","volume":"1648","author":"Valenzuela","year":"2016","journal-title":"Brain Res."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature12985","article-title":"Mitochondrial form and function","volume":"505","author":"Friedman","year":"2014","journal-title":"Nature"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"9324018","DOI":"10.1155\/2019\/9324018","article-title":"Crosstalk between Calcium and ROS in Pathophysiological Conditions","volume":"2019","author":"Feno","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.irn.2019.05.002","article-title":"Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes","volume":"145","author":"Rumora","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.irn.2019.05.001","article-title":"Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy","volume":"145","author":"Trecarichi","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0004.2008.01097.x","article-title":"Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients","volume":"75","author":"Olsson","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/ejhg.2010.36","article-title":"TTR familial amyloid polyneuropathy: Does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?","volume":"18","author":"Bonaiti","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1152\/ajpendo.00314.2018","article-title":"Mitochondrial dysfunction in type 2 diabetes mellitus: An organ-based analysis","volume":"316","author":"Pinti","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/bs.pmbts.2016.12.019","article-title":"Mitochondrial Perturbation in Alzheimer\u2019s Disease and Diabetes","volume":"146","author":"Akhter","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST20170501","article-title":"Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: Can mitochondria be targeted therapeutically?","volume":"46","author":"Macdonald","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/pmic.200900651","article-title":"Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction","volume":"10","author":"Lim","year":"2010","journal-title":"Proteomics"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-018-03651-9","article-title":"Conformational switching within dynamic oligomers underpins toxic gain-of-function by diabetes-associated amyloid","volume":"9","author":"Birol","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fncel.2019.00022","article-title":"Amyloid beta Oligomers Increase ER-Mitochondria Ca(2+) Cross Talk in Young Hippocampal Neurons and Exacerbate Aging-Induced Intracellular Ca(2+) Remodeling","volume":"13","author":"Nunez","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.1713129115","article-title":"alpha-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies","volume":"115","author":"Prots","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Azevedo, E.P., Guimaraes-Costa, A.B., Bandeira-Melo, C., Chimelli, L., Waddington-Cruz, M., Saraiva, E.M., Palhano, F.L., and Foguel, D. (2019). Inflammatory profiling of patients with familial amyloid polyneuropathy. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1369-4"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pro.3425","article-title":"The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies","volume":"27","author":"Abedini","year":"2018","journal-title":"Protein Sci."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Paudel, Y.N., Angelopoulou, E., Piperi, C., Othman, I., Aamir, K., and Shaikh, M.F. (2020). Impact of HMGB1, RAGE, and TLR4 in Alzheimer\u2019s Disease (AD): From Risk Factors to Therapeutic Targeting. Cells, 9.","DOI":"10.3390\/cells9020383"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"403460","DOI":"10.1155\/2013\/403460","article-title":"Receptor for advanced glycation end products and its involvement in inflammatory diseases","volume":"2013","author":"Chuah","year":"2013","journal-title":"Int. J. Inflamm."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: Past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/labinvest.3780116","article-title":"Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation","volume":"80","author":"Sousa","year":"2000","journal-title":"Lab. Investig."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1096\/fj.04-1900com","article-title":"RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways","volume":"18","author":"Rong","year":"2004","journal-title":"FASEB J."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2013.08.018","article-title":"Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons","volume":"249","author":"Saleh","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ejp.775","article-title":"A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse","volume":"20","author":"Brederson","year":"2016","journal-title":"Eur. J. Pain"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation","volume":"38","author":"Verri","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncel.2018.00072","article-title":"An Inflammation-Centric View of Neurological Disease: Beyond the Neuron","volume":"12","author":"Skaper","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2018.11.041","article-title":"Targeting inflammatory components in neuropathic pain: The analgesic effect of thymulin related peptide","volume":"702","author":"Nomikos","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/rheumatology\/kex308","article-title":"Divergent roles of immune cells and their mediators in pain","volume":"57","author":"Raoof","year":"2018","journal-title":"Rheumatology"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"16019","DOI":"10.1038\/cddiscovery.2016.19","article-title":"Questions and controversies in innate immune research: What is the physiological role of NLRP3?","volume":"2","author":"Coll","year":"2016","journal-title":"Cell Death Discov."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Migita, K., Izumi, Y., Jiuchi, Y., Kozuru, H., Kawahara, C., Nakamura, M., Nakamura, T., Agematsu, K., Masumoto, J., and Yasunami, M. (2014). Serum amyloid A induces NLRP-3-mediated IL-1beta secretion in neutrophils. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096703"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cei.12458","article-title":"Serum amyloid A induces interleukin-1beta secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome","volume":"179","author":"Yu","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/JPER.19-0050","article-title":"The interaction between serum amyloid A and Toll-like receptor 2 pathway regulates inflammatory cytokine secretion in human gingival fibroblasts","volume":"91","author":"Song","year":"2020","journal-title":"J. Periodontol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cmet.2013.05.001","article-title":"Inflammation in obesity and diabetes: Islet dysfunction and therapeutic opportunity","volume":"17","author":"Donath","year":"2013","journal-title":"Cell Metab."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI88877","article-title":"Islet inflammation in type 2 diabetes and physiology","volume":"127","author":"Eguchi","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1172\/JCI85210","article-title":"RAGE binds preamyloid IAPP intermediates and mediates pancreatic beta cell proteotoxicity","volume":"128","author":"Abedini","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2337\/db13-0863","article-title":"Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1beta production and beta-cell dysfunction","volume":"63","author":"Ehses","year":"2014","journal-title":"Diabetes"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/dom.12873","article-title":"Dual role of interleukin-1beta in islet amyloid formation and its beta-cell toxicity: Implications for type 2 diabetes and islet transplantation","volume":"19","author":"Park","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12035-016-9702-z","article-title":"Association Between Tumor Necrosis Factor-alpha and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: A Meta-Analysis","volume":"54","author":"Mu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","article-title":"Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer\u2019s disease","volume":"35","author":"Hanzel","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1007\/s12035-019-1638-7","article-title":"The Role of Neuronal NLRP1 Inflammasome in Alzheimer\u2019s Disease: Bringing Neurons into the Neuroinflammation Game","volume":"56","author":"Yap","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.intimp.2018.12.027","article-title":"HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-kappaB signaling in primary hippocampal neurons induced by Abeta25-35","volume":"67","author":"Nan","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2008.05.014","article-title":"Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal","volume":"213","author":"Tang","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imcb.12301","article-title":"The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer\u2019s disease","volume":"98","author":"Webers","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2174\/1567205016666191106094356","article-title":"Common Pathological Mechanisms and Risk Factors for Alzheimer\u2019s Disease and Type-2 Diabetes: Focus on Inflammation","volume":"16","author":"Moyse","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-160488","article-title":"Inflammation, Antiinflammatory Agents, and Alzheimer\u2019s Disease: The Last 22 Years","volume":"54","author":"McGeer","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.4103\/1673-5374.167773","article-title":"The HMGB1 signaling pathway activates the inflammatory response in Schwann cells","volume":"10","author":"Man","year":"2015","journal-title":"Neural Regen. Res."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phrs.2016.03.038","article-title":"Modulation of endothelial function by Toll like receptors","volume":"108","author":"Salvador","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2019.01.006","article-title":"Anagliptin ameliorates high glucose-induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1","volume":"107","author":"Jiang","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"113849","DOI":"10.1016\/j.bcp.2020.113849","article-title":"Thrombin\/PAR-1 activation induces endothelial damages via NLRP1 inflammasome in gestational diabetes","volume":"175","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/labinvest.2013.83","article-title":"Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis","volume":"93","author":"Misumi","year":"2013","journal-title":"Lab. Investig."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnmol.2017.00138","article-title":"Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy","volume":"10","author":"Fella","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Panayiotou, E., Fella, E., Papacharalambous, R., Malas, S., Saraiva, M.J., and Kyriakides, T. (2017). C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175767"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1523-1755.1999.055003899.x","article-title":"Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis","volume":"55","author":"Durfort","year":"1999","journal-title":"Kidney Int."},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Okoshi, T., Yamaguchi, I., Ozawa, D., Hasegawa, K., and Naiki, H. (2015). Endocytosed 2-Microglobulin Amyloid Fibrils Induce Necrosis and Apoptosis of Rabbit Synovial Fibroblasts by Disrupting Endosomal\/Lysosomal Membranes: A Novel Mechanism on the Cytotoxicity of Amyloid Fibrils. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139330"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Suenaga, G., Ikeda, T., Komohara, Y., Takamatsu, K., Kakuma, T., Tasaki, M., Misumi, Y., Ueda, M., Ito, T., and Senju, S. (2016). Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163944"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2013.01.025","article-title":"Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1beta secretion in association with alterations in cellular redox and energy status","volume":"60","author":"Jabaut","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J. Immunol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"13257","DOI":"10.1074\/jbc.RA118.002428","article-title":"High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation","volume":"293","author":"Shridas","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/icb.2014.4","article-title":"Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes","volume":"92","author":"Nackiewicz","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"7597382","DOI":"10.1155\/2019\/7597382","article-title":"Infiltration of Blood-Derived Macrophages Contributes to the Development of Diabetic Neuropathy","volume":"2019","author":"Sun","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_276","first-page":"69","article-title":"Cytokine production capabilities of human primary monocyte-derived macrophages from patients with diabetes mellitus type 2 with and without diabetic peripheral neuropathy","volume":"12","author":"Grosick","year":"2019","journal-title":"J. Pain Res."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.01.057","article-title":"Activated microglia in the spinal cord underlies diabetic neuropathic pain","volume":"728","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1038\/cddis.2013.325","article-title":"Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis","volume":"4","author":"Azevedo","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1523\/JNEUROSCI.0801-19.2019","article-title":"Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia","volume":"39","author":"Yu","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: Is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41467-019-13839-2","article-title":"Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdi.12379","article-title":"Microglia in the spinal cord and neuropathic pain","volume":"7","author":"Tsuda","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2019.00025","article-title":"Neurons and Microglia; A Sickly-Sweet Duo in Diabetic Pain Neuropathy","volume":"13","author":"Rajchgot","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_288","first-page":"2121","article-title":"Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy","volume":"8","author":"Li","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1042\/CS20160075","article-title":"Impairment of autophagy by TTR V30M aggregates: In vivo reversal by TUDCA and curcumin","volume":"130","author":"Teixeira","year":"2016","journal-title":"Clin. Sci. Lond."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.npep.2019.03.005","article-title":"Autophagy dysfunction in neuropathic pain","volume":"75","author":"Liu","year":"2019","journal-title":"Neuropeptides"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"9185368","DOI":"10.1155\/2018\/9185368","article-title":"Impaired Autophagy of GABAergic Interneurons in Neuropathic Pain","volume":"2018","author":"Yin","year":"2018","journal-title":"Pain Res. Manag."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fnmol.2017.00143","article-title":"Autophagy as an Emerging Common Pathomechanism in Inherited Peripheral Neuropathies","volume":"10","author":"Haidar","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1172\/JCI69625","article-title":"Amyloidogenic peptide oligomer accumulation in autophagy-deficient beta cells induces diabetes","volume":"124","author":"Kim","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2014.144","article-title":"Diabetes: Protective role of autophagy in pancreatic beta cells","volume":"10","author":"Osorio","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1172\/JCI71981","article-title":"Autophagy defends pancreatic beta cells from human islet amyloid polypeptide-induced toxicity","volume":"124","author":"Rivera","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.molmet.2019.06.014","article-title":"beta-cell autophagy: Mechanism and role in beta-cell dysfunction","volume":"27","author":"Lee","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/hmg\/ddy154","article-title":"Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer\u2019s disease","volume":"27","author":"Reddy","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","article-title":"Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Manczak","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/dna.2014.2757","article-title":"Alzheimer\u2019s disease-related misfolded proteins and dysfunctional organelles on autophagy menu","volume":"34","author":"Correia","year":"2015","journal-title":"DNA Cell Biol."},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Reddy, P.H., and Oliver, D.M. (2019). Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer\u2019s Disease. Cells, 8.","DOI":"10.3390\/cells8050488"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2018.05.017","article-title":"Alzheimer\u2019s disease and the autophagic-lysosomal system","volume":"697","author":"Chung","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Plaza-Zabala, A., Sierra-Torre, V., and Sierra, A. (2017). Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030598"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arr.2015.01.003","article-title":"DAMPs as mediators of sterile inflammation in aging-related pathologies","volume":"24","author":"Feldman","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.arr.2015.02.005","article-title":"Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: A ticking time bomb in ageing","volume":"24","author":"Kapetanovic","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"ref_306","doi-asserted-by":"crossref","unstructured":"Mputhia, Z., Hone, E., Tripathi, T., Sargeant, T., Martins, R., and Bharadwaj, P. (2019). Autophagy Modulation as a Treatment of Amyloid Diseases. Molecules, 24.","DOI":"10.3390\/molecules24183372"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/13506129.2003.12088561","article-title":"Familial amyloid polyneuropathy: Mechanisms leading to nerve degeneration","volume":"10","author":"Said","year":"2003","journal-title":"Amyloid"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1212\/WNL.0000000000005777","article-title":"Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy","volume":"91","author":"Lozeron","year":"2018","journal-title":"Neurology"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fncel.2019.00116","article-title":"Emerging Role of Schwann Cells in Neuropathic Pain: Receptors, Glial Mediators and Myelination","volume":"13","author":"Wei","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jnc.13068","article-title":"Schwann cells contribute to neurodegeneration in transthyretin amyloidosis","volume":"134","author":"Murakami","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/glia.22382","article-title":"Local production of serum amyloid a is implicated in the induction of macrophage chemoattractants in Schwann cells during wallerian degeneration of peripheral nerves","volume":"60","author":"Jang","year":"2012","journal-title":"Glia"},{"key":"ref_313","doi-asserted-by":"crossref","unstructured":"Koike, H., and Katsuno, M. (2019). Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights. Biomedicines, 7.","DOI":"10.3390\/biomedicines7010011"},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: A model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/ndt\/17.8.1450","article-title":"Vascular involvement and cell damage in experimental AA and clinical beta(2)-microglobulin amyloidosis","volume":"17","author":"Mourad","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/ATVBAHA.115.306349","article-title":"Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis","volume":"36","author":"Belmokhtar","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_317","first-page":"4941379","article-title":"Serum Amyloid A Induces a Vascular Smooth Muscle Cell Phenotype Switch through the p38 MAPK Signaling Pathway","volume":"2017","author":"Zhang","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"7150509","DOI":"10.1155\/2016\/7150509","article-title":"Serum Amyloid A Promotes E-Selectin Expression via Toll-Like Receptor 2 in Human Aortic Endothelial Cells","volume":"2016","author":"Nishida","year":"2016","journal-title":"Mediators Inflamm."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"11101","DOI":"10.3390\/ijms160511101","article-title":"Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells","volume":"16","author":"Chami","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1369\/0022155415573324","article-title":"Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 Diabetes","volume":"63","author":"Brissova","year":"2015","journal-title":"J. Histochem. Cytochem."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3181\/0709-RM-251","article-title":"Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes","volume":"233","author":"Hayden","year":"2008","journal-title":"Exp. Biol. Med. Maywood"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: A complication of islet dysfunction or an aetiological factor in Type 2 diabetes?","volume":"47","author":"Clark","year":"2004","journal-title":"Diabetologia"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.24992","article-title":"Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia","volume":"82","author":"Ly","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1073\/pnas.89.6.2218","article-title":"Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy","volume":"89","author":"Poduslo","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-010-0783-x","article-title":"Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult","volume":"121","author":"Mizisin","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3389\/fnins.2018.01038","article-title":"Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy","volume":"12","author":"Richner","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.1073\/pnas.0901533106","article-title":"p75 reduces beta-amyloid-induced sympathetic innervation deficits in an Alzheimer\u2019s disease mouse model","volume":"106","author":"Bengoechea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/6\/1553\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:10Z","timestamp":1760175790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/6\/1553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":327,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["cells9061553"],"URL":"https:\/\/doi.org\/10.3390\/cells9061553","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}